Agilent Jan 20, 2026 Agilent Technologies (A) Initiated with "Buy" Rating by HSBC | A Stock News - GuruFocus
Illumina Jan 20, 2026 Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside - Insider Monkey
BioPharma Dive Jan 20, 2026 When every day counts: Building CRO partnerships on a foundation of trust, care and precision
Illumina Jan 20, 2026 Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside - Yahoo Finance
Agilent Jan 20, 2026 HSBC initiates coverage on Agilent stock with Buy rating, $180 target - Investing.com
Vertex Jan 20, 2026 Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th - Vertex Pharmaceuticals Newsroom
Endpoints News Jan 20, 2026 Exciva raises $59M Series B to fund Phase 2 test of Alzheimer’s agitation drug
Illumina Jan 20, 2026 The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance
Illumina Jan 20, 2026 The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance Singapore
Agilent Jan 20, 2026 Nucleotide Market Is Going to Boom | Agilent Technologies • Bio-Rad Laboratories • QIAGEN - openPR.com
Waters Jan 20, 2026 Is Waters Corporation the Quiet Wall Street Cheat Code Everyone’s Sleeping On? - AD HOC NEWS
Waters Jan 20, 2026 Is Waters Corporation the Quiet Wall Street Cheat Code Everyone’s Sleeping On? - AD HOC NEWS
eLife Jan 20, 2026 Identification of a sub-population of synovial mesenchymal stem cells with enhanced treatment efficacy in a rat model of osteoarthritis